XCUR Chart
See on advanced chart >
About
Exicure, Inc. was founded on July 9, 2015. The company is a clinical-stage biotechnology company developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on their proprietary Spherical Nucleic Acid, or SNA, technology.
Read More
- HighlightAn early-stage biotechnology company that developing nucleic acid therapies targeting RNA to address neurological disorders and hair loss disorders
- ExchangeNASDAQ
- Listing Date07/31/2019
- Established Date07/09/2015
- Full-time Employees6
- Address2430 N. Halsted St. Chicago IL 60614
- Tel1-847-6731700
- Website
- Fiscal Year End Date12/31
- Security TypeCommon Stock
Industry
Pharmaceuticals